Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More – ResearchAndMarkets.com

DUBLIN–( SERVICE CORD)– The “Antisense & RNAi Rehabs – A Global Market Introduction” record has actually been included in ResearchAndMarkets.com’s offering. The international market for Antisense & RNAi Rehabs is approximated at US$ 5.4 billion in 2024 and is prepared for to upload a CAGR of 17.8% throughout the 2024-2030 evaluation duration and stand at a forecasted US$ 14.4 billion by 2030. The Antisense & RNAi rehabs market development is largely driven by developments in medication distribution modern technologies, lik

发布者:Dr.Durant,转转请注明出处:https://robotalks.cn/antisense-rnai-therapeutics-market-report-2024-featuring-profiles-of-alnylam-pharmaceuticals-arbutus-biopharma-benitec-biopharma-gsk-ionis-pharmaceuticals-sanofi-sarepta-therapeutics-amp/

(0)
上一篇 12 12 月, 2024 11:57 上午
下一篇 12 12 月, 2024

相关推荐

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。